Amedisys: Q3 Earnings Insights

Comments
Loading...

Amedisys AMED reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Amedisys missed estimated earnings by 5.74%, reporting an EPS of $1.15 versus an estimate of $1.22.

Revenue was up $4.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.24 which was followed by a 4.81% drop in the share price the next day.

Here's a look at Amedisys's past performance:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 1.23 1.12 1.18 1.36
EPS Actual 1.47 1.23 1.18 1.53
Revenue Estimate 583.12M 558.84M 555.20M 568.37M
Revenue Actual 557.89M 545.26M 559.32M 553.49M

To track all earnings releases for Amedisys visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMED Logo
AMEDAmedisys Inc
$91.510.01%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
66.15
Growth
83.30
Quality
42.14
Value
23.71
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: